Cargando…
Gene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma
BACKGROUND: Resistance to trastuzumab is often observed in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and has been shown to involve multiple potential mechanisms. We examined the ability of microarray analyses to determine the potential markers of pathological...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768465/ https://www.ncbi.nlm.nih.gov/pubmed/19755993 http://dx.doi.org/10.1038/sj.bjc.6605310 |